Overview

Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Status:
Completed
Trial end date:
2009-09-02
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to to assess the pharmacokinetics of paroxetine after single doses of paroxetine CR at the dose levels of 12.5, 25 and 50mg in healthy Japanese male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine